Related Experiment Video
Updated: Apr 19, 2026
12:19
Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
Published on: April 10, 2026
17
Preparing to provide MTM services
Zandra M Glenn1, Soheyla L Mahdavian2, Todd J Woodard3
1Econometrica Inc, Bethseda, MD, USA zglenn@econometricainc.com.
Journal of Pharmacy Practice
|December 28, 2014
Summary
Medication Therapy Management (MTM) enhances pharmacists' roles in healthcare. Addressing reimbursement challenges is key for pharmacists to fully contribute to patient care and improve health outcomes.
Area of Science:
- Pharmacy practice and healthcare policy
- Clinical outcomes research
- Health economics
Background:
- The US healthcare system faces pressure for improved clinical and economic outcomes.
- Pharmacists are increasingly recognized as integral members of the healthcare team.
- The Medicare Modernization Act of 2003 acknowledged pharmacists' expertise in managing patient medication therapy.
Purpose of the Study:
- To explore the evolving role of pharmacists in healthcare.
- To examine the significance of Medication Therapy Management (MTM) and Collaboration Practice Agreements (CPA).
- To identify challenges, particularly reimbursement, faced by pharmacists providing MTM services.
Main Methods:
- Review of healthcare policy and professional practice guidelines.
- Analysis of the impact of MTM and CPA on pharmacist roles.
- Examination of economic factors influencing pharmacist service provision.
Main Results:
- MTM programs and CPA are expanding the pharmacist's role in patient care.
- Pharmacists possess unique expertise to identify and resolve medication therapy problems.
- Reimbursement for pharmacist-provided services remains a significant barrier.
Conclusions:
- Pharmacists are essential for optimizing patient medication therapy and improving health outcomes.
- Policy and practice changes are needed to ensure adequate reimbursement for MTM services.
- Further integration of pharmacists into multidisciplinary teams can enhance healthcare delivery.
Related Concept Videos
01:16Therapeutic Drug Monitoring: Overview and Classification
582
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
582
01:28Drug Therapy
423
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
423
01:29Therapeutic Drug Monitoring: Affecting Factors
400
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
400
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
327
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
327
01:24Mania and Antimanic Drugs: Overview
802
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
802
01:26Mitral Stenosis III: Medical Management
488
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
488